Autoantibodies in Human Diabetic Depression Inhibit Adult Neural Progenitor Cells In vitro and Induce Depressive-Like Behavior in Rodents
Journal Title: Journal of Endocrinology and Diabetes - Year 2015, Vol 2, Issue 2
Abstract
Aim: Diabetic depression increases in association with microvascular complications. We tested a hypothesis that circulating autoantibodies having anti-endothelial and anti-neuronal properties increase in subsets of diabetes with co-morbid depression. Methods: Protein-A eluates from plasma of 20 diabetic depression patients and 30 age-matched controls were tested for effects on endothelial cell survival, neurite outgrowth in rat pheochromocytoma (PC12) cells, or process extension and survival in adult rat dentate gyrus neural progenitor cells. The protein-A eluates from depressed or non-depressed, diabetic patients were injected (via intracerebroventricular route) into mice and 7-10 days later behavioral tests (sucrose preference, and tail suspension tests) were conducted to determine whether the autoantibodies induced anhedonia or despair. Results: Diabetic depression (n=20) autoantibodies caused a significant inhibition of PC12 cell neurite outgrowth (P<0.001) or endothelial cell proliferation compared to autoantibodies in control, diabetic (n=20) or non-diabetic (n=10) patients without depression. Process extension and survival in adult rat dentate gyrus neural progenitor cells was significantly reduced (P<0.001) by diabetic depression autoantibodies (n= 11) compared to the effects from similar concentrations (5-7 μg/mL) of autoantibodies in diabetic (n=12) or non-diabetic patients without depression (n=7). Ten micromolar concentrations of Y27632, a selective Rho-Associated Protein Kinase (ROCK) inhibitor, significantly prevented (P<0.0001) neural progenitor cell process retraction induced by diabetes depression autoantibodies (n=5). Mice treated with diabetic depression autoantibodies (n=16 from two different patients’ autoantibodies) exhibited significantly reduced (P=0.027) sucrose preference (anhedonia) compared to mice treated with diabetic control autoantibodies (n=16 from two different patients’ autoantibodies). Conclusion: These data suggest that autoantibodies in a subset of older adult diabetic depression inhibit endothelial cell survival, and impair process extension and survival in adult dentate gyrus neural progenitor cells in vitro.
Authors and Affiliations
Mark B Zimering, Joseph A Behnke, Smita Thakker-Varia, Janet Alder
3-Iodothyronamine: A High Potency Metabolic Hormone and its Potential for Therapeutic Applications
3-Iodothyronamide (T1AM) is a naturally produced endogenous hormone like molecule. Only recently it has been discovered in the past decade, the proceeding body of research emerging from its initial discovery has revealed...
Lipid Profile of Type 2 Diabetic Patients at a Tertiary Hospital in Tanzania: Cross Sectional Study
Background: Patients with diabetes mellitus are at high risk of cardiovascular events because of abnormal lipid status. Dyslipidemia is common in diabetes mellitus and is associated with cardiovascular complications. Ear...
Correlation of Glycemic Status with Plasma Fibrinogen Level in Insulin Dependent as Well as Noninsulin Dependent Diabetic Patients
Aims and objective: Fibrinogen is an indicator of an inflammatory vascular changes and endothelial dysfunction. It has been identified as an independent risk factor for cardiovascular disease and it is closely associated...
Evaluating Osteoporotic Fracture Risk in Latin American Countries
The epidemiology of osteoporosis (OP) has been extensively studied especially in countries of the northern hemisphere (USA, Europe), while in Latin America (LA) data is scarce in relation to the North American or Europea...
Prevalence of Metabolic Syndrome and Associated Risk Factors in Medical Students of Universidad Central Del Ecuador
Introduction: There is evidence that obesity increases cardiovascular risk and Metabolic Syndrome (MS) in children, adolescents and adults. Inflammation plays an important role in the development of these diseases. Today...